Barbara Mino

2.2k total citations
27 papers, 1.1k citations indexed

About

Barbara Mino is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Barbara Mino has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Barbara Mino's work include Microtubule and mitosis dynamics (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Lung Cancer Research Studies (4 papers). Barbara Mino is often cited by papers focused on Microtubule and mitosis dynamics (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Lung Cancer Research Studies (4 papers). Barbara Mino collaborates with scholars based in United States, Canada and Japan. Barbara Mino's co-authors include Jaime Rodriguez‐Canales, Ignacio I. Wistuba, Pamela Villalobos, Edwin R. Parra, Carmen Behrens, Don L. Gibbons, J. Jack Lee, John V. Heymach, Pan Tong and Jason Roszik and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Barbara Mino

27 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Mino United States 18 620 458 254 225 217 27 1.1k
Andrew J. Colebatch Australia 15 516 0.8× 272 0.6× 91 0.4× 126 0.6× 173 0.8× 34 792
Elizabeth Ruth Plummer United Kingdom 19 961 1.6× 836 1.8× 116 0.5× 181 0.8× 137 0.6× 69 1.3k
Liu‐Xiao Yang China 25 496 0.8× 538 1.2× 186 0.7× 443 2.0× 148 0.7× 44 1.3k
Aeree Kim South Korea 20 444 0.7× 548 1.2× 109 0.4× 264 1.2× 171 0.8× 42 1.0k
Laure Cayrefourcq France 19 1.1k 1.7× 412 0.9× 285 1.1× 831 3.7× 165 0.8× 34 1.4k
Alexey Aleshin United States 21 863 1.4× 491 1.1× 583 2.3× 828 3.7× 68 0.3× 90 1.6k
Fengkai Xu China 17 246 0.4× 645 1.4× 199 0.8× 319 1.4× 171 0.8× 35 983
Mei‐Kuang Chen United States 12 912 1.5× 527 1.2× 191 0.8× 131 0.6× 348 1.6× 24 1.2k
Daisuke Arai Japan 14 417 0.7× 428 0.9× 505 2.0× 165 0.7× 41 0.2× 48 876
Sara Akhavanfard United States 8 356 0.6× 801 1.7× 248 1.0× 504 2.2× 75 0.3× 15 1.4k

Countries citing papers authored by Barbara Mino

Since Specialization
Citations

This map shows the geographic impact of Barbara Mino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Mino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Mino more than expected).

Fields of papers citing papers by Barbara Mino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Mino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Mino. The network helps show where Barbara Mino may publish in the future.

Co-authorship network of co-authors of Barbara Mino

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Mino. A scholar is included among the top collaborators of Barbara Mino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Mino. Barbara Mino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kasiri, Sahba, Baozhi Chen, Barbara Mino, et al.. (2020). Stromal Hedgehog pathway activation by IHH suppresses lung adenocarcinoma growth and metastasis by limiting reactive oxygen species. Oncogene. 39(16). 3258–3275. 18 indexed citations
2.
Behrens, Carmen, Pedro Rocha, Edwin R. Parra, et al.. (2020). Female Gender Predicts Augmented Immune Infiltration in Lung Adenocarcinoma. Clinical Lung Cancer. 22(3). e415–e424. 12 indexed citations
3.
Hight, Suzie K., Rahul K. Kollipara, Elizabeth A. McMillan, et al.. (2020). An in vivo functional genomics screen of nuclear receptors and their co-regulators identifies FOXA1 as an essential gene in lung tumorigenesis. Neoplasia. 22(8). 294–310. 25 indexed citations
4.
Parra, Edwin R., Mei Jiang, Luisa M. Solis, et al.. (2020). Procedural Requirements and Recommendations for Multiplex Immunofluorescence Tyramide Signal Amplification Assays to Support Translational Oncology Studies. Cancers. 12(2). 255–255. 44 indexed citations
5.
Zheng, Lin, Zibo Chen, Masanori Kawakami, et al.. (2019). Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy. Molecular Cancer Therapeutics. 18(10). 1775–1786. 27 indexed citations
6.
Aung, Phyu P., Edwin R. Parra, Souptik Barua, et al.. (2019). B7-H3 Expression in Merkel Cell Carcinoma–Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density. Clinical Cancer Research. 25(11). 3455–3467. 29 indexed citations
7.
Tong, Zhimin, Anuj Verma, Arlene M. Correa, et al.. (2019). Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma. Therapeutic Advances in Medical Oncology. 11. 3862479890–3862479890. 14 indexed citations
8.
Tong, Zhimin, Anuj Verma, Arlene M. Correa, et al.. (2019). Abstract 3859: Targeting CDK9 and MCL-1 by a New CDK9/p-TEFB Inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma. Cancer Research. 79(13_Supplement). 3859–3859. 1 indexed citations
9.
Parra, Edwin R., Pamela Villalobos, Jiexin Zhang, et al.. (2018). Immunohistochemical and Image Analysis-Based Study Shows That Several Immune Checkpoints are Co-expressed in Non–Small Cell Lung Carcinoma Tumors. Journal of Thoracic Oncology. 13(6). 779–791. 50 indexed citations
10.
Mustachio, Lisa Maria, Yun Lu, Laura J. Tafe, et al.. (2017). Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer. Molecular Cancer Research. 15(7). 905–914. 34 indexed citations
11.
Schliekelman, Mark J., Chad J. Creighton, Brandi N. Baird, et al.. (2017). Thy-1+ Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis. Scientific Reports. 7(1). 6478–6478. 40 indexed citations
12.
Parra, Edwin R., Pamela Villalobos, Barbara Mino, & Jaime Rodriguez‐Canales. (2017). Comparison of Different Antibody Clones for Immunohistochemistry Detection of Programmed Cell Death Ligand 1 (PD-L1) on Non–Small Cell Lung Carcinoma. Applied immunohistochemistry & molecular morphology. 26(2). 83–93. 105 indexed citations
13.
Tong, Zhimin, Jianhu Zhang, Yawei Qiao, et al.. (2017). Targeting cyclin-dependent kinase 9 enhances sensitization to ionizing radiation in esophageal adenocarcinoma and identifies AXL as a novel downstream target. European Journal of Surgical Oncology. 43(11). 2222–2222. 1 indexed citations
14.
Parra, Edwin R., Carmen Behrens, Jaime Rodriguez‐Canales, et al.. (2016). Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients. Clinical Cancer Research. 22(24). 6278–6289. 103 indexed citations
15.
Feldmeyer, Laurence, Courtney W. Hudgens, Priyadharsini Nagarajan, et al.. (2016). Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell Carcinoma. Clinical Cancer Research. 22(22). 5553–5563. 86 indexed citations
16.
Peng, David H., Christin Ungewiss, Pan Tong, et al.. (2016). ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis. Oncogene. 36(14). 1925–1938. 162 indexed citations
17.
Mustachio, Lisa Maria, Masanori Kawakami, Yun Lu, et al.. (2016). The ISG15-specific protease USP18 regulates stability of PTEN. Oncotarget. 8(1). 3–14. 41 indexed citations
18.
Parra, Edwin R., Carmen Behrens, Jaime Rodriguez‐Canales, et al.. (2015). Abstract 4256: High programmed cell death ligand 1 expression and low immune infiltrate score correlate with worse outcome in patients with lung adenocarcinoma. Cancer Research. 75(15_Supplement). 4256–4256. 2 indexed citations
19.
Riquelme, Erick, Milind Suraokar, Jaime Rodriguez‐Canales, et al.. (2014). Frequent Coamplification and Cooperation between C-MYC and PVT1 Oncogenes Promote Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 9(7). 998–1007. 79 indexed citations
20.
Massarelli, Erminia, Amir Onn, Edith M. Marom, et al.. (2014). Vandetanib and Indwelling Pleural Catheter for Non–Small-Cell Lung Cancer With Recurrent Malignant Pleural Effusion. Clinical Lung Cancer. 15(5). 379–386. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026